BC
GILD icon

Bridgefront Capital’s Gilead Sciences GILD Stock Holding History

Bridgefront Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.95M Buy
+15,448
New +$2.04M 0.51% 33
2025
Q3 		– Sell
-3,924
Closed -$435K – 672
2025
Q2 		$435K Buy
+3,924
New +$418K 0.12% 308
2024
Q2 		– Sell
-9,424
Closed -$690K – 552
2024
Q1 		$690K Buy
+9,424
New +$725K 0.52% 32
2023
Q3 		– Sell
-5,890
Closed -$454K – 471
2023
Q2 		$454K Buy
+5,890
New +$470K 0.25% 136
2022
Q3 		– Sell
-3,564
Closed -$220K – 372
2022
Q2 		$220K Buy
+3,564
New +$221K 0.24% 207
2021
Q3 		– Sell
-4,039
Closed -$278K – 472
2021
Q2 		$278K Buy
+4,039
New +$270K 0.1% 376

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bridgefront Capital's GILD Position: Q2 2026 in Review

Bridgefront Capital opened a new position in Gilead Sciences (GILD) in Q2 2026: 15,448 shares worth $1.95M. The stake represents 0.51% of the portfolio and ranks #33 among its holdings. This is a return to the name: Bridgefront Capital previously reported a position in GILD as recently as Q2 2025.

Bridgefront Capital first reported a position in GILD in Q2 2021 and has held it in 6 quarters since. 2,277 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Bridgefront Capital held 15,448 shares of Gilead Sciences worth $1.95M as of Q2 2026.
  • Gilead Sciences was a new Bridgefront Capital position in Q2 2026.
  • Gilead Sciences made up 0.51% of Bridgefront Capital's portfolio in Q2 2026, its #33 holding.
  • Bridgefront Capital first reported a position in Gilead Sciences in Q2 2021 and has held it in 6 quarters since.
  • 2,277 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.